UK NSC moves to 2-yearly open call cycle
UK NSC moves to 2-yearly open call cycle
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
UK NSC is moving to a 2-yearly cycle for inviting stakeholders to submit new screening topic proposals.
The practical evaluation of screening for severe combined immunodeficiency in English NHS services is being extended until the end of March 2024. Interim data from the evaluation is encouraging.
A summary note has been published of the latest meeting of the UK National Screening Committee's Blood Spot Task Group when members were updated on progress on 4 of its 5 core projects.
Researchers are being invited to apply to lead a prospective evaluation study on the use of artificial intelligence in breast screening.
The Lancet has published an article setting out the priorities for the effective implementation of targeted lung cancer screening in the UK.
The UK NSC's new expert research sub-group is getting to grips with an important and varied workload.
We've extended the deadline to apply for one of the 12 vacancies on the UK NSC's expert groups to Friday, 21 April 2023.
Multi-cancer early detection tests, which hold out the hope of detecting dozens of cancers before symptoms emerge, present a major but exciting new challenge for the UK National Screening Committee and its processes for reviewing evidence.
The UK's independent expert screening committee organised a risk stratification modelling event for researchers to showcase their work and outline possible improvements to the NHS Breast Screening Programme.
Apply for one of 12 exciting vacancies in the expert reference groups that support the UK National Screening Committee.
Twelve companies from around the world attended a UK National Screening Committee virtual event to share information on the development of multi-cancer early detection tests and how these tests might eventually lead to exciting developments in the UK’s cancer screening programmes.